199 related articles for article (PubMed ID: 32446903)
1. LncRNA XIST modulates 5-hydroxytrytophan-induced visceral hypersensitivity by epigenetic silencing of the SERT gene in mice with diarrhea-predominant IBS.
Zhang Y; Zhang H; Zhang W; Zhang Y; Wang W; Nie L
Cell Signal; 2020 Sep; 73():109674. PubMed ID: 32446903
[TBL] [Abstract][Full Text] [Related]
2. Mucosal Serotonin Reuptake Transporter Expression in Irritable Bowel Syndrome Is Modulated by Gut Microbiota Via Mast Cell-Prostaglandin E2.
Gao J; Xiong T; Grabauskas G; Owyang C
Gastroenterology; 2022 Jun; 162(7):1962-1974.e6. PubMed ID: 35167867
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor upregulates serotonin transporter and its association with visceral hypersensitivity in irritable bowel syndrome.
Cui XF; Zhou WM; Yang Y; Zhou J; Li XL; Lin L; Zhang HJ
World J Gastroenterol; 2014 Oct; 20(37):13521-9. PubMed ID: 25309082
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 5-hydroxytryptophan signaling pathway characteristics in diarrhea-predominant irritable bowel syndrome and ulcerative colitis.
Yu FY; Huang SG; Zhang HY; Ye H; Chi HG; Zou Y; Lv RX; Zheng XB
World J Gastroenterol; 2016 Mar; 22(12):3451-9. PubMed ID: 27022227
[TBL] [Abstract][Full Text] [Related]
5. Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients.
Kerckhoffs AP; Ter Linde JJ; Akkermans LM; Samsom M
Neurogastroenterol Motil; 2008 Aug; 20(8):900-7. PubMed ID: 18363639
[TBL] [Abstract][Full Text] [Related]
6. SERT and TPH-1 mRNA expression are reduced in irritable bowel syndrome patients regardless of visceral sensitivity state in large intestine.
Kerckhoffs AP; ter Linde JJ; Akkermans LM; Samsom M
Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(9):G1053-60. PubMed ID: 22323131
[TBL] [Abstract][Full Text] [Related]
7. Impaired uptake of serotonin by platelets from patients with irritable bowel syndrome correlates with duodenal immune activation.
Foley S; Garsed K; Singh G; Duroudier NP; Swan C; Hall IP; Zaitoun A; Bennett A; Marsden C; Holmes G; Walls A; Spiller RC
Gastroenterology; 2011 May; 140(5):1434-43.e1. PubMed ID: 21315720
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-24 inhibits serotonin reuptake transporter expression and aggravates irritable bowel syndrome.
Liao XJ; Mao WM; Wang Q; Yang GG; Wu WJ; Shao SX
Biochem Biophys Res Commun; 2016 Jan; 469(2):288-93. PubMed ID: 26631964
[TBL] [Abstract][Full Text] [Related]
9. Colonic mucosal N-methyl-D-aspartate receptor mediated visceral hypersensitivity in a mouse model of irritable bowel syndrome.
Qi QQ; Chen FX; Zhao DY; Li LX; Wang P; Li YQ; Zuo XL
J Dig Dis; 2016 Jul; 17(7):448-57. PubMed ID: 27356126
[TBL] [Abstract][Full Text] [Related]
10. Interferon-γ is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism.
Barbaro MR; Di Sabatino A; Cremon C; Giuffrida P; Fiorentino M; Altimari A; Bellacosa L; Stanghellini V; Barbara G
Am J Physiol Gastrointest Liver Physiol; 2016 Mar; 310(6):G439-47. PubMed ID: 26744473
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of brain-derived neurotrophic factor is correlated with visceral hypersensitivity in patients with diarrhea-predominant irritable bowel syndrome.
Zhang Y; Qin G; Liu DR; Wang Y; Yao SK
World J Gastroenterol; 2019 Jan; 25(2):269-281. PubMed ID: 30670915
[TBL] [Abstract][Full Text] [Related]
12. Serotonin transporter gene promoter region polymorphisms and serotonin transporter expression in the colonic mucosa of irritable bowel syndrome patients.
Wang YM; Chang Y; Chang YY; Cheng J; Li J; Wang T; Zhang QY; Liang DC; Sun B; Wang BM
Neurogastroenterol Motil; 2012 Jun; 24(6):560-5, e254-5. PubMed ID: 22435794
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-200a Targets Cannabinoid Receptor 1 and Serotonin Transporter to Increase Visceral Hyperalgesia in Diarrhea-predominant Irritable Bowel Syndrome Rats.
Hou Q; Huang Y; Zhang C; Zhu S; Li P; Chen X; Hou Z; Liu F
J Neurogastroenterol Motil; 2018 Oct; 24(4):656-668. PubMed ID: 30347941
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the serotonin transporter in the pathogenesis of irritable bowel syndrome.
Jin DC; Cao HL; Xu MQ; Wang SN; Wang YM; Yan F; Wang BM
World J Gastroenterol; 2016 Sep; 22(36):8137-48. PubMed ID: 27688655
[TBL] [Abstract][Full Text] [Related]
15. Increased intestinal mucosal leptin levels in patients with diarrhea-predominant irritable bowel syndrome.
Liu DR; Xu XJ; Yao SK
World J Gastroenterol; 2018 Jan; 24(1):46-57. PubMed ID: 29358881
[TBL] [Abstract][Full Text] [Related]
16. [The relationship between adherens junction and tight junction and clinical symptoms in patients with diarrhea predominant irritable bowel syndrome].
Zhang M; Chen CY; Hu Y; Lyu B
Zhonghua Nei Ke Za Zhi; 2020 Jan; 59(1):40-46. PubMed ID: 31887835
[No Abstract] [Full Text] [Related]
17. Serotonin transporter and cholecystokinin in diarrhea-predominant irritable bowel syndrome: Associations with abdominal pain, visceral hypersensitivity and psychological performance.
Qin G; Zhang Y; Yao SK
World J Clin Cases; 2020 May; 8(9):1632-1641. PubMed ID: 32432141
[TBL] [Abstract][Full Text] [Related]
18. Effect of the 5-HT4 receptor and serotonin transporter on visceral hypersensitivity in rats.
Yan C; Xin-Guang L; Hua-Hong W; Jun-Xia L; Yi-Xuan L
Braz J Med Biol Res; 2012 Oct; 45(10):948-54. PubMed ID: 22832600
[TBL] [Abstract][Full Text] [Related]
19. Effect of
Cao YN; Feng LJ; Liu YY; Jiang K; Zhang MJ; Gu YX; Wang BM; Gao J; Wang ZL; Wang YM
World J Gastroenterol; 2018 Jan; 24(3):338-350. PubMed ID: 29391756
[TBL] [Abstract][Full Text] [Related]
20. [Moxibustion relieves abdominal hypersensitivity and diarrhea by regulating colonic 5-hydroxytryptamine signaling pathway in rats with diarrhea type irritable bowel syndrome].
Tong L; Wu LB; Li N; Cheng HL; Cai RL; Chu HR
Zhen Ci Yan Jiu; 2020 Jul; 45(7):535-40. PubMed ID: 32705826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
